Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Quotient Limited QTNT
$0.38
+$2.43 (639.30%)
На 18:00, 12 мая 2023
+15 689.47%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
0.00000000
-
week52high
88.80
-
week52low
0.18
-
Revenue
38514000
-
P/E TTM
0
-
Beta
0.00000000
-
EPS
0.00000000
-
Last Dividend
0.00000000
-
Next Earnings Date
15 февр 2023 г. в 01:27
Описание компании
Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, commercializes, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology, serological disease screening, and molecular disease screening. Its conventional reagent products for blood grouping include antisera products that are used to identify blood group antigens; reagent red blood cells, which enable the identification of blood group antibodies; whole blood control products for use as daily quality assurance tests; and ancillary products that are used to support blood grouping. The company also offers MosaiQ SDS Microarray that is designed as a serological disease screening microarray comprised assays to detect cytomegalovirus and Syphilis; MosaiQ MDS Microarray that is designed as a molecular disease screening microarray test for donor red cells or source plasma; MosaiQ IH Microarray as a blood grouping microarray; MosaiQ Autoimmune Microarray; MosaiQ COVID-19; and MosaiQ IH3 Microarray. It sells its products to hospitals, donor collection agencies, independent testing laboratories, original equipment manufacturers, and blood banking operation and other diagnostics companies. Quotient Limited was founded in 2007 and is headquartered in Eysins, Switzerland.
Рекомендации
аналитиков
Рекомендации аналитиков
Grading company | New grade | Previous grade | Recommendation date |
---|---|---|---|
Cowen & Co. | Outperform | Outperform | 29 июн 2022 г. |
BTIG | Buy | Buy | 29 июн 2022 г. |
Goldman Sachs | Neutral | Neutral | 19 апр 2022 г. |
Goldman Sachs | Neutral | Neutral | 03 дек 2021 г. |
Goldman Sachs | Neutral | Neutral | 06 авг 2021 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
---|---|---|---|---|
Buckle Isabelle | D | 2 | 1014 | 25 ноя 2022 г. |
Kiboro Ali | D | 1526 | 1526 | 19 ноя 2022 г. |
Kiboro Ali | A | 3192 | 1526 | 19 ноя 2022 г. |
von Prondzynski Heino | D | 10578 | 25000 | 18 ноя 2022 г. |
Larue Catherine | A | 40000 | 40000 | 31 окт 2022 г. |
Larue Catherine | A | 70000 | 70000 | 31 окт 2022 г. |
Larue Catherine | A | 0 | 6917 | 31 окт 2022 г. |
Larue Catherine | A | 47211 | 6917 | 31 окт 2022 г. |
McDonough Brian | A | 40000 | 40000 | 31 окт 2022 г. |
McDonough Brian | A | 70000 | 70000 | 31 окт 2022 г. |
Новостная лента
Penny Stocks Risk Management: 3 Tips and Tricks
PennyStocks
30 дек 2022 г. в 06:00
Use these penny stocks risk management tips for trading The post Penny Stocks Risk Management: 3 Tips and Tricks appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Penny Stocks Day Trading: 3 Techniques to Use in 2023
PennyStocks
28 дек 2022 г. в 06:00
Use these techniques for day trading penny stocks The post Penny Stocks Day Trading: 3 Techniques to Use in 2023 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Why Quotient Technology Stock Soared More Than 25% Higher Today
The Motley Fool
09 ноя 2022 г. в 15:39
The digital marketing specialist refinanced a massive convertible debt load and gained market share in a difficult market environment.
Quotient Limited (QTNT) CEO Manuel Mendez on Q1 2023 Results - Earnings Call Transcript
Seeking Alpha
09 авг 2022 г. в 13:14
Quotient Limited (NASDAQ:QTNT ) Q1 2023 Earnings Conference Call August 9, 2022 8:30 AM ET Company Participants Ali Kiboro - Chief Financial Officer Manuel Mendez - Chief Executive Officer Conference Call Participants Josh Jennings - Cowen Brandon Couillard - Jefferies Matt Sykes - Goldman Sachs Operator Greetings and welcome to the Quotient Limited First Quarter Fiscal Year 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Quotient (QTNT) Reports Q1 Loss, Lags Revenue Estimates
Zacks Investment Research
09 авг 2022 г. в 09:47
Quotient (QTNT) delivered earnings and revenue surprises of -32.14% and 6.23%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?